Joshua Hare bought $350k of LGVN
Chief Scientific Officer at Longeveron Inc.. 148,936 shares at an average of $2.35, traded Apr 10, 2024, filed Apr 12, 2024.
Score components
- +15RoleOfficer
- +15Trade size$350k at market
- +6Relative to holdingsHoldings up 31%
- +8Price context94% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.9%, 3m +159.8%, 6m +5.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001214659-24-006773, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 10, 2024 | POpen-market purchase Class A Common Stock | +106,383 | $2.35 | $250k | 590,727 | Apr 12, 2024 |
| Apr 11, 2024 | POpen-market purchase Class A Common Stock | +42,553 | $2.35 | $100k | 633,280 | Apr 12, 2024 |
| Apr 10, 2024 | POpen-market purchase Warrant (right to buy)derivative | +106,383 | $0.13 | $13k | 106,383 | Apr 12, 2024 |
| Apr 11, 2024 | POpen-market purchase Warrant (right to buy)derivative | +42,553 | $0.13 | $5,319 | 42,553 | Apr 12, 2024 |
Related signals
Other insiders at Longeveron Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | Longeveron Inc. | Rock Soffer director | $27k 21,000 shares | -9% | |
| 23Weak | Longeveron Inc. | Rock Soffer director | $2,640 2,000 shares | -1% | |
| 23Weak | Longeveron Inc. | Joshua Hare Chief Scientific Officer | $7,367 5,250 shares | -1% | |
| 15Weak | LGVNsell Longeveron Inc. | Khoso Baluch director | $2,588 1,250 shares | -5% | |
| 68Notable | Longeveron Inc. | Mohamed Wa'el Ahmed Hashad Chief Executive Officer | $25k 10,638 shares | +118% | |
| 63Notable | Longeveron Inc. | Rock Soffer director | $325k 138,298 shares | +197% | |
| 58Moderate | Longeveron Inc. | Cathy Ross director | $6,545 5,000 shares | +100% | |
| 48Moderate | Longeveron Inc. | Khoso Baluch director | $14k 10,000 shares | +200% | |
| 48Moderate | Longeveron Inc. | Jeffrey Pfeffer director | $14k 10,000 shares | +200% | |
| 3Weak | Longeveron Inc. | Joshua Hare Chief Scientific Officer | $75k 20,000 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.